Mc Adam, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Mc Adam, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	BUY	$0.6 - $1.11 $0 - $1	1 Added 0.01%	10,006 $6,000
Q2 2021 Aug 02, 2021	BUY	$1.39 - $2.21 $13,906 - $22,111	10,005 New	10,005 $14,000
Q2 2018 Aug 22, 2018	SELL	$5.05 - $6.8 $505 - $680	-100 Closed	0 $0
Q1 2018 Apr 24, 2018	BUY	$5.6 - $9.25 $560 - $925	100 New	100 $1,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.